Transtheoretical Model Based Nursing Interventions on Smoking Cessation in Patients With COPD

NCT04313738 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-09-07

No results posted yet for this study

Summary

Background: The aim of this study is to evaluate the efficiency of nursing intervention based on smoking cessation transtheoretical model in patients with COPD who smoke Method: Experimental design was used in the study. Thirty-three patients in the study group were completed with 35 chronic obstructive pulmonary disease patients in the control group. Sociodemographic characteristics data form, Fagerstrom Nicotine Dependency Test, Transteoretic Model Decision Making Scale, Self-efficacy Scale, Change Stages Scale and Behavior Modification Scale were used as data collection form. In the analysis of the data, the significance test of the difference between the two means, the significance test of the difference between two peers, the two-ratio test, Chi square, Mann Withney U test and Wilcoxon test were used.

Results: Decision-making subscale scores, self-efficacy score scores, and behavior modification methods subscale scores showed significant increases (p\<.05) in the decision-making subscale of the patients in the experimental group after the home nursing interventions (p\<.05). While there was a significant improvement in the change stages, 9 patients in the experimental group and 2 patients in the control group had left the cigarette but the difference between them was significant (p\<.05).

What does this paper contribute?

* Nursing interventions with home visits based on transtheoretical model supplied to quit smoking of patients
* The nursing interventions with home visits based on transtheoretical model contributed positively to behavioral change in patients' smoking cessation.

Conditions

  • COPD
  • Smoking Cessation
  • Home Visit

Interventions

OTHER

Assigned Interventions

Home visit, health education

Sponsors & Collaborators

  • Dokuz Eylul University

    lead OTHER

Principal Investigators

  • Figen Cavusoglu, Asst. Prof · Ondokuz Mayıs University

  • Ayse Beser, Prof · Koç University

  • Oguz Kılınc, Prof · Dokuz Eylul University

  • Nazmiye Tibel Tuna, Asst Prof · Ondokuz Mayıs University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-01
Primary Completion
2017-11-15
Completion
2018-02-18

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04313738 on ClinicalTrials.gov